OPCI 2019

07 March

7:00 PM America/New_York

2D

Videos open video

OPCI

Best ways to measure FFR and iFR - Pitfalls and case examples

open video

OPCI

Detection of vulnerable and lipid-rich plaque using NIRS and other technologies…

open video

OPCI

BOOM Technique for Ostial Lesions

open video

OPCI

Using iFR Co-Registration

open video

OPCI

High Definition IVUS as a tool to optimize PCI

open video

OPCI

HD IVUS Case Comparisons

open video

OPCI

FFR Measurements with a Catheter-Based Technique: What Does the Data tell us?

open video

OPCI

OCT: Basic Imaging Interpretation and Interesting Cases

open video

OPCI

Intravascular Imaging is Only Beneficial in Select Cases

open video

OPCI

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

open video

OPCI

HD IVUS technology and clinical studies

open video

OPCI

Physiologic Lesion Assessment Can Be Misleading and is Not Practical in Every...

open video

OPCI

Show Me the Data: Evidence That Physiologic Lesion Assessment Improves...

open video

OPCI

The Value of Intravascular Imaging for Left Main and Complex Bifurcation PCI

open video

OPCI

OCT Guided Treatment of Calcified Lesions

open video

OPCI

Derivation and Validation of the Resting-Full Cycle Ration (RFR) VALIDATE and...

open video

OPCI

Imaging and physiology - guided PCI without contrast administration - Case

open video

OPCI

Physiology Cases that Rocked my World

open video

OPCI

Femoral Access is Tried and True and Gives the Most Reliable Results

open video

OPCI

Use of Adjunctive Technology in CTO and Complex Cases - How Intravascular…

open video

OPCI

AUC for PCI - Not Everybody Needs to be Revascularized

open video

OPCI

FFRCT - Changing Practice

open video

OPCI

New options in coronary physiology - When to use what

open video

OPCI

Stent failures - Identifying causes of stent thrombosis and restenosis and...

open video

OPCI

Is it Appropriate to Always Follow Appropriate Use Criteria (AUC)?

open video

OPCI

I can do Precision PCI from the wrist and get even better results!

open video

OPCI

Coronary Angiography-Derived FFR

open video

OPCI

Coronary physiology in acute coronary syndromes - To test or not to test

open video

OPCI

Optimal Duration of Antiplatelet Therapy - Does IV Imaging Make a Difference?

open video

OPCI

CT Imaging in Ischemic Heart Disease:CTA, CT-FFR, and CT-Perfusion- When to...

open video

OPCI

Always Finish with FFR-Post PCI Assessment and Clinical Outcomes

open video

OPCI

Atherectomy, Less is More

open video

OPCI

Intravascular Imaging Should Be Used Routinely for All PCI

open video

OPCI

Impact of Intracoronary Imaging on the Evolution of PCI - From Balloon...

open video

OPCI

OCT and IVUS are invaluable in my practice - Case examples

open video

OPCI

When treating (severely) calcified CAD, rotational or orbital atherectomy is...

open video

OPCI

Physiologic Lesion Assessmentis Mandatory for Every PCI in Stable CAD

open video

OPCI

A Case of LM iFR/FFR When Nothing Works

open video

OPCI

Best Practice for Contemporary PCI-Precision PCI and Beyond

Speakers

Ajay Kirtane

Ajay J. Kirtane, MD, SM, is a Professor of Medicine at Columbia University Medical Center and Director of the Cardiac Catheterization Laboratories at New York Presbyterian Hospital. Dr. Kirtane is a graduate of Princeton University and Columbia University College of Physicians and Surgeons, and completed his residency in Internal Medicine at the University of California – San Francisco. Dr. Kirtane is a practicing Cardiologist with an interest in coronary and peripheral intervention and assumed the directorship of the NYP/Columbia cardiac catheterization laboratories in 2015. In addition to his clinical commitments at CUMC, Dr. Kirtane has a strong interest in clinical education and research, serving as Chief Academic Officer of the Center for Interventional Vascular Therapy. On the national and international level, he is a co-director of the Cardiovascular Research Foundation’s Transcatheter Cardiovascular Therapeutics meeting, has served as a director of several international, national, and regional educational meetings, and has participated on the program committees for the scientific sessions of both the American College of Cardiology and American Heart Association. Dr. Kirtane’s research interests are in clinical trial methodology and outcomes of device-based and pharmacologic interventions in Interventional Cardiology. He has authored/co-authored >150 original manuscripts and >50 reviews and chapters including the “Coronary Stenting” chapters of the two most widely used textbooks in Interventional Cardiology.

Akiko Maehara

Dr. Maehara is the Director of the Intravascular Imaging Core Laboratory at the CRF Clinical Trials Center. She is also an Assistant Professor of Medicine at Columbia University College of Physicians and Surgeons in New York. She is a leading authority in the field of intravascular imaging and physiology. Dr. Maehara received her medical degree from Yamaguchi University School of Medicine in Yamaguchi, Japan. She completed her cardiovascular fellowship at the Cardiovascular Center in Toranomon Hospital in Tokyo. Dr. Maehara finished a research fellowship at Stanford University and at the Washington Hospital Center in Washington, DC.

Allen Jeremias

Allen Jeremias, MD, MSc, is the Director of Interventional Cardiology Research and Associate Director of the Cardiac Catheterization Laboratory at St. Francis Hospital in Roslyn, New York. He is also a member of the Cardiovascular Research Foundation in New York City where he currently serves as the Director of the Physiology Core Laboratory. He completed his medical training at The Cleveland Clinic Foundation, Stanford University School of Medicine, and Harvard Medical School. He has been a high volume interventional cardiologist since 2006 and recognized as a Top Doctor in the New York Metro Area by Castle Connolly. Dr. Jeremias has significantly contributed to advancing the field of interventional cardiology and he is considered one of the foremost authorities in coronary physiology and intravascular imaging. He is a co-director of the annual St. Francis Intravascular Imaging and Coronary Physiology Workshop, teaching physicians around the world on “Precision Angioplasty”. Dr. Jeremias is presently engaged in a major global study that could change the path of treating clogged arteries. Known as the ILUMIEN IV trial, this major clinical study is evaluating Optical Coherence Tomography (OCT) to guide coronary stent placement. He is also the principal investigator of DEFINE PCI, an international study on assessing the improvement in blood flow after stent placement for severe coronary blockages.

Arnold Seto

Arnold Seto MD MPA is the Director of Interventional Cardiology Research at University of California, Irvine and Cath Lab Director at the Long Beach Veterans Affairs Medical Center. He was an active participant in the DEFINE-FLAIR and DEFINE-PCI trials, and a steering committee member for DEFINE-PCI. He has published multiple manuscripts in coronary artery disease, coronary physiology, and vascular access especially in the areas of accurate measurement of FFR and ultrasound guidance for radial and femoral access.

Bruce Samuels

Dr. Bruce Samuels is an interventional cardiologist on staff at Cedars-Sinai Medical Center (CSMC) in Los Angeles, California. Dr. Samuels completed his medical studies at Albert Einstein College of Medicine in New York before returning to Southern California to complete his residency and chief residency in Internal Medicine at Harbor-UCLA Medical Center. At CSMC, he trained in both general and interventional cardiology before joining the medical staff there. In addition to his clinical practice in coronary intervention, Dr. Samuels has actively participated in numerous interventional trials including IVUS guided therapy, coronary physiology and microvascular disease. He is also working closely with the Barbra Streisand Women’s Heart Center based at CSMC, working as an interventionalist in the active coronary reactivity research there. As co-chair of a 30-day readmissions task force, he has helped to shape policy for CSMC in its efforts to improve quality delivery of care. He has frequently been invited as faculty to many scientific meetings and is a sought after speaker for numerous peer educational platforms. Dr. Samuels is a fellow of the American College of Cardiology and is Board Certified in Internal Medicine, Cardiovascular Diseases, and Interventional Cardiology. He is married with three sons; his outside interests include contemporary art and long distance running.

Dimitri Karmpaliotis

Dr. Karmpaliotis is a member of the Center for Interventional Vascular Therapy at Columbia University Medical Center. Dr. Karmpaliotis specializes in advanced, complex coronary intervention. He brings a wealth of experience in percutaneous coronary interventions. Dr. Karmpaliotis graduated from the University of Athens School of Health Sciences and trained at the prestigious Beth Israel Deaconess Medical Center at Harvard Medical School. Dr. Karmpaliotis was instrumental in building a world-class interventional cardiology program at Piedmont Heart Center in Atlanta, Georgia and has contributed to building one of the largest complex PCI programs in the world at CUMC. He also serves as the co-director of the US CTO Summit Dr. Karmpaliotis has served as principal investigator on more than 50 clinical trials, with special interest in the development of techniques for treating chronic total occlusions in coronary arteries.

Emmanouil Brilakis

Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FESC, FSCAI is Director of the Center for Complex Coronary Interventions at the Minneapolis Heart Institute and Chairman of the Center for Coronary Artery Disease at the Minneapolis Heart Institute Foundation. After graduating from Lycee Leonin de Patissia, Dr. Brilakis received his medical degree from the National Kapodistrian University of Athens, Greece. He trained in Internal Medicine, Cardiovascular Diseases and Interventional Cardiology at the Mayo Clinic. He also completed a Masters in Clinical Research at the Mayo Clinic and a PhD in Clinical Research at the National Kapodistrian University of Athens, Greece. He served as director of the cardiac catheterization laboratories at VA North Texas Health Care System from 2004-2016. He was on the faculty of the University of Texas Southwestern Medical School from 2004-2018. Dr. Brilakis leads a large clinical trial group investigating treatment of chronic total occlusions, prevention and treatment of saphenous vein graft disease, prevention and management of complications, intracoronary imaging, antiplatelet treatment optimization post coronary stenting, radiation safety in the catheterization laboratory, and implementation of novel technologies in healthcare. Dr. Brilakis has authored or co-authored over 600 manuscripts and has written the Manual of CTO Interventions, now in its second edition. He directs the Complex Coronary Interventions Webcast series and is on the Board of the Cardiovascular Innovations Foundation. He is an associate editor for Circulation and an editorial board member and reviewer for several journals and grant agencies. He is lecturing and proctoring at several institutions in the United States and abroad.

Erick Schampaert

An interventional cardiologist at Sacred Heart Hospital of Montreal, Division of Cardiology. Features in 4 videos on Wondr Medical. Erick Schampaert generally speaks on Bifurcation, Intravascular Ultrasound (IVUS), Coronary Optical Coherence Tomography (OCT), Drug Eluting Stents (DES), and Fractional Flow Reserve (FFR).

Evan Shlofmitz

Dr. Evan Shlofmitz is an Interventional Cardiologist and the Director of Intravascular Imaging at St. Francis Hospital - The Heart Center in Roslyn, NY. He completed a fellowship in Interventional Cardiology at Georgetown University/MedStar Washington Hospital Center. He previously completed an Intravascular Imaging and Physiology fellowship at the Cardiovascular Research Foundation (CRF) and Columbia University Medical Center (CUMC), a Cardiovascular Disease fellowship at Northwell Health and served as Chief Resident for Internal Medicine at New York Presbyterian Queens. Dr. Shlofmitz has a strong interest in clinical education and research, lecturing internationally. He is a course director for Optimizing PCI (O-PCI) and CRT's Imaging & Physiology course and serves on SCAI's Ischemic Heart Disease Council and the steering committee for the IMPROVE trial. His research interests have centered on intravascular imaging, the treatment of calcified coronary artery disease, in-stent restenosis and the optimization of stent implantation, with more than 125 publications in peer-reviewed journals.

Gary Mintz

Gary S. Mintz, Chief Medical Officer of the Cardiovascular Research Foundation, the Managing Co-Director of Transcatheter Cardiovascular Therapeutics (TCT), and Editor-In-Chief of www.tctmd.com. Dr. Mintz has extensive experience in both interventional cardiology and cardiovascular imaging, in particular intravascular imaging and physiology. He joined the Cardiovascular Research Foundation in 1991 as Director of the Coronary Ultrasound Program that has made fundamental observations about the pathology, pathogenesis, and mechanisms of coronary atherosclerosis, catheter-based interventions, and restenosis. He is the author of almost 1000 articles or book chapters and 800 abstracts concerning various aspects of clinical cardiology, cardiac ultrasound, hemodynamics, cardiac radiology and coronary arteriography, interventional cardiology, and intravascular imaging and physiology. In 2005, Dr. Mintz published the single-authored textbook Intracoronary Ultrasound that has now been translated into Chinese.

Habib Samady

Dr. Habib Samady trained in general cardiology, nuclear cardiology and interventional cardiology at Yale University. He joined Emory University in 2005. In 2009, he became Professor of Medicine and in 2011, Director of Interventional Cardiology at Emory University. He has received several outstanding teaching awards. Dr. Samady has an actively funded clinical and translational research program to investigate: - Hemodynamic mechanisms associated with progression of human coronary atherosclerosis - Evaluation of pharmaceutical agents for treatment of coronary microvascular disease, endothelial dysfunction, coronary vasospasm and non obstructive atherosclerosis - Biomechanics of permanent and Bioresorbable coronary vascular devices Dr. Samady is Deputy Editor of JACC Cardiovascular Interventions, is on the editorial board of numerous cardiovascular journals, and is extensively published.

Hector Garcia-Garcia

Hector M. Garcia-Garcia, MD, PhD, is now serving as an attending cardiologist for MedStar Heart & Vascular Institute and director of the Coronary Invasive Imaging Core Lab. Prior to joining the MHVI medical staff, Dr. Garcia-Garcia served as Director of the Core Lab of Invasive Imaging at Cardialysis—a leading cardiology clinical research organization—and as researcher at the Erasmus Medical Center in Rotterdam, The Netherlands and Inselspital in Bern, Switzerland. He received both a Master’s and Doctorate degree from the Erasmus University of Rotterdam. An accomplished researcher, Dr. Garcia-Garcia has widely published in many international medical journals (more than 530 publications - H-index of 61), authored book chapters in most renowned cardiovascular textbooks and has presented at cardiology conferences world-wide. He is an expert in innovative cardiovascular technology. He has mentored seven PhD students and published their thesis.

Hiram Bezerra

Hiram Bezerra, MD, PhD, is Director, Cardiovascular Imaging Core Laboratory as well as Director, Director, Advanced Coronary and MCS at University Hospital Cleveland Medical Center. He is also an Associate Professor, Medicine at Case Western Reserve University School of Medicine. Previously, he served at Massachusetts General Hospital with extensive expertise in Cardiac Imaging, Interventional Cardiology, Optical Coherence Tomography and Computed Tomography.

J. Jane Cao

Jane Cao, MD, MPH, FACC, is St. Francis Hospital’s Director of Research and Cardiac Imaging. She is a nationally renowned cardiac imaging specialist and researcher. Dr. Cao received her degree from the Medical College of Fudan Uni­versity in Shanghai, and completed her Residency in Internal Medicine and Fellowship in Cardiology at the University of Vermont. She earned a Master’s Degree in Biology at Smith College in Massachusetts, and an MPH at the Harvard School of Public Health. Prior to coming to St. Francis, Dr. Cao was a Senior Research Fellow at the National Institutes of Health. She has lectured extensively in both the U.S. and China on cardiac CT and MRI.

Jeffrey Moses

An internationally recognized interventional cardiologist, Dr. Moses has performed more than 15,000 interventional procedures, authored over 600 publications, and served as lead investigator for numerous national and international clinical studies that have demonstrated the effectiveness and safety of coronary stent placement. In 2002, Dr. Moses was the lead investigator on a large clinical trial, the first in the U.S. that demonstrated the enormous benefit that led to FDA approval of the first drug-coated stent now used in the majority of interventional procedures in the U.S. Most recently in on the Executive Committee of PARTNER trial; they brought the first transcatheter aortic valve to clinical use in the U.S. He currently serves as Director of Interventional Cardiovascular Therapeutics at Columbia University Medical Center and as Director of Advanced Cardiac Interventions at St Francis Hospital and Heart Center in Roslyn, NY. He is also a pioneer in developing approaches involving minimally invasive surgery, angioplasty, gene therapy, novel imaging technologies and various support devices that allow for wider application of interventional cardiovascular procedures.

Justin Davies

Dr Justin Davies is a clinical academic and consultant interventional cardiologist at the National Heart and Lung Institute, Imperial College London. After training at Imperial College, he won a prestigious BHF research fellowship to study arterial haemodynamics. Since then he has continued to work on the development of mathematical algorithms to aid understanding of large artery physiology and to develop new tools to assess arterial disease. The holder of several patents, he has published widely in the field of hypertension, coronary and large artery physiology and is the winner of many national and international awards. He has several international collaborations, and is the developer of iFR and the co-principal investigator of the ADVISE studies, the DEFINE-FLAIR, ORBITA and DEFINE-PCI studies. Justin also has an interest in renal denervation, and has lead the first-in-man studies to evaluate the safety of this technique to patients with chronic systolic heart failure (REACH studies).

Manesh PATEL

Manesh Patel is the Chief of the Division of Cardiology and the Division of Clinical Pharmacology. His clinical interests include diagnostic and interventional coronary angiography, peripheral angiography and endovascular intervention. His is involved in several clinical trials involving patients with cardiovascular disease and in cardiac imaging. He is also the Chair of the American College of Cardiology Task Force for Appropriate Use Criteria for Cardiovascular Procedures and is Chair of the American Heart Association Diagnostic and Interventional Cath Committee. Patel's interest in cardiac imaging, quality of care, cardiac devices is also evident in his research. His integration of these efforts into his roles at Duke was recognized in 2010 when he received the prestigious Duke Cardiology Fellowship Mentor Award. In 2011, Dr. Patel was named the endowed John Bush Simpson Assistant Professor of Cardiology. In 2013, Dr. Patel received the Robert M. Califf Faculty clinical research Award. Currently, Dr. Patel is leading an effort to redesign the delivery of care to patients undergoing invasive catheterization procedures in the health system with a specific aim of measure and providing individualized, patient centered, innovative, and efficient care.

Matthew Price

Matthew Price, MD, is Director of the Cardiac Catheterization Laboratory and a member of the Division of Cardiovascular Diseases at Scripps Clinic, in La Jolla, California. Dr Price earned his medical degree from the University of California, Los Angeles (UCLA) School of Medicine and completed his internship and residency in internal medicine at the UCLA Center for Health Sciences. He subsequently completed a fellowship in Cardiovascular Diseases at Cedars-Sinai Medical Center in Los Angeles, where he held the position of Chief Fellow. Dr Price completed his training in interventional cardiology at Scripps Clinic, in La Jolla, California. Dr Price’s clinical and research focus includes interventional approaches to structural heart and coronary disease. He has led several clinical trials in PCI, and currently serves on the Steering and/or Executive committee of clinical trials evaluating antiplatelet therapy, novel drug-eluting stents, intravascular imaging, and left atrial appendage closure. He is a member of the Steering Committee of the ACC NCDR Left Atrial Appendage Occlusion (LAAO) registry. He has been twice awarded the Scripps Clinic Chairman’s Award for Research in Medicine. Dr Price serves as Editor-in-Chief of Interventional Cardiology Clinics and is a Section Editor for the Journal of the American College of Cardiology, He has authored or co-authored more than 140 peer-reviewed manuscripts, including publications in the New England Journal of Medicine, JAMA, the European Heart Journal, Circulation, and the Journal of the American College of Cardiology. He is also Editor of the seminal text-book, “Coronary Stenting”.

Michael Lee

Dr. Michael S. Lee, is an interventional cardiologist, Associate Professor of Medicine and the Associate Director of Interventional Cardiology Research at the UCLA Medical Center. Dr. Lee has published over 110 (over 70 of which were as first author) peer reviewed articles and chapters. He has also published on topics including antithrombotic therapy in patients with acute coronary syndrome and in percutaneous coronary intervention, protocols to establish heparin dosing regimens, and percutaneous coronary intervention for the treatment of left main disease, saphenous vein grafts, and cardiac allograft vasculopathy who have undergone orthotopic heart transplantation. He is one of the world’s authorities in coronary and peripheral orbital atherectomy.

Paul Lee

Paul J. Lee, M.D., earned his medical degree at SUNY Buffalo in 1994. He completed his residency at Montefiore Medical Center continuing at North Shore-Long Island Jewish, then completed his Interventional Cardiology Fellowship in 2002. He joined South Bay Cardiovascular in 2002, performing cardiac interventions at Good Samaritan and Southside Hospitals. In 2009, South Bay Cardiovascular affiliated with St. Francis Hospital, becoming one of the largest and most respected cardiovascular practices in the region. Dr. Lee specializes in treatment of complex coronary artery disease and peripheral vascular disease and TAVR procedures.

Paul Teirstein

Paul Teirstein, MD, is the Chief of Cardiology and Director of Interventional Cardiology for Scripps Clinic and Director of the Scripps Prebys Cardiovascular Institute for Scripps Health. With a primary focus on complex coronary interventions and new technology development, Dr. Teirstein has played an active role in the initial development and clinical investigation of coronary stent procedures, rotablator atherectomy, coronary angioscopy and the utilization of cardiopulmonary support. Dr. Teirstein pioneered the first effective treatment for restenosis (low dose radiation therapy) and was one of the early investigators of medicated and bioabsorbable stents. Recent areas of investigation include new technology for minimally invasive transcatheter aortic valve replacement (TAVR). Dr. Teirstein currently performs in excess of 800 stent procedures per year and maintains an active clinical research and teaching unit at Scripps Clinic where he strives to offer patients the most advanced cardiovascular care available worldwide.

Richard Shlofmitz

Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.

Ron Waksman

Ron Waksman, MD, FACC, Associate Director, Division of Cardiology, MedStar Washington Hospital Center (MWHC) and Director of Cardiovascular Research and Advanced Education for the MedStar Heart and Vascular Institute at the MedStar Washington Hospital Center. With nearly 20 years of experience in leading edge medical technologies, Dr. Waksman is a world-renowned interventional cardiologist and is a highly sought after Principal Investigator for pre-clinical and clinical studies conducted in the United States and abroad. Dr Waksman has performed over 5000 coronary interventions throughout his career.

Roxana Mehran

A consultant cardiologist at Mount Sinai Hospital, New York, USA. Features in 13 videos on Wondr Medical. Roxana Mehran generally speaks on Anti-Platelet Drugs , Coronary Optical Coherence Tomography (OCT), Intravascular Ultrasound (IVUS), Cardiovascular Pharmacotherapy, and Cardiac Valves.

Sunil Rao

Works at Duke University Health System, North Carolina, USA. Features in 7 videos on Wondr Medical. Sunil Rao generally speaks on Radial, Coronary Optical Coherence Tomography (OCT), Fractional Flow Reserve (FFR), Intravascular Ultrasound (IVUS), and Instantaneous wave-Free Ratio (iFR).

William Fearon

Features in 10 videos on Wondr Medical. William Fearon generally speaks on Stable Coronary Artery Disease (CAD), Coronary Physiology, Fractional Flow Reserve (FFR), Angio FFR/iFR, and Instantaneous wave-Free Ratio (iFR).

Ziad Ali

Ziad Ali is the Director of the DeMatteis Cardiovascular Institute, Director of Investigational Interventional Cardiology, and Director of Cardio-nephrology at St Francis Hospital & Heart Center in New York. He is also Director of the Angiographic Core Laboratory at Cardiovascular Research Foundation and Associate Professor of Medicine at Columbia University Medical Center. His clinical research interests focus on the use of intravascular imaging and physiology technologies such as optical coherence tomography, intravascular ultrasound, and flow wire assessment to optimize coronary interventions, for which he has served as a Global principal investigator on a number of trials. Dr. Ali is also a recognized innovator, playing an integral role in the development of the Resting Full-Cycle Ratio (RFR) and Shockwave intravascular lithotripsy. Clinically Dr. Ali developed pioneering techniques to perform vascular interventions without contrast administration, including IVUS-guided zero-contrast PCI and OCT using saline flush media, protecting patients with advanced kidney disease from acute kidney injury and the need for dialysis.